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Twelve long-term cell lines were established from peripheral blood mononuclear cells (PBMC) or cerebrospinal fluid cells of patients with human T lymphotropic virus type I (HTLV-I) seropositive tropical spastic paraparesis (TSP) originating from the French West Indies, French Guyana or the Central African Republic. Most of these long-term interleukin-2-dependent cell lines exhibited a pattern characteristic ofCD4+-activated T cells with high expression of CD2, CD3-and-CD4 antigens, associated with a strong density of TAC and DR molecules. Nevertheless, in five cases CD8 expression was present at a significant level. HTLV-I antigens were never detected in uncultured PBMC, but they were expressed in a few cells after short-term culture and after 4 months the majority of the cells were HTLV-I positive, as demonstrated by indirect immunofluorescence (IF) using polyclonal or monoclonal anti-pl9 and anti-p24 antibodies. Low and variable levels of reverse transcriptase activity were detected in supernatant fluids of these cell lines only after 4 months of culture, when at least 50% of the cells exhibited HTLV-I antigens by IF. However, numerous type C HTLV-I-Iike viral particles were detected, mostly in the extraceUular spaces, with rare budding particles. Similar findings were found in three T cell lines derived from West Indian and African patients with adult T-cell leukaemia/lymphoma (ATLL). Differences in high M, polypeptides were detected by Western blot in cell lysates when compar
Introduction
Human T lymphotropic virus type I (HTLV-I), a type C retrovirus discovered in 1980 (Poiesz et al., 1980 (Poiesz et al., , 1981 is recognized to be aetiologically associated with adult T cell leukaemia/lymphoma (ATLL) , a lymphoproliferative malignancy characterized by monoclonal expansion of CD4 lymphocytes. HTLV-I infection is highly prevalent in certain geographical areas, such as southern Japan (Yamamoto & Hinuma, 1985) , the Caribbean region (Blattner et al., 1982) and Africa (Fleming et al., 1986) , where between 1 and 30~ of the general population, depending on sex, age and location, have serum HTLV-I antibodies. These subjects are considered to be healthy carriers of the virus because HTLV-I can be isolated from their peripheral blood lymphocytes in culture, but fewer than 1 ~ of them will develop ATLL during their lifetime. We have previously demonstrated (Gessain et al., 1985) the presence of specific HTLV-I antibodies in serum and cerebrospinal fluid (CSF) of patients from Martinique (French West Indies) who have a chronic progressive myelopathy referred to as tropical spastic paraparesis (TSP). We proposed that HTLV-I, or a closely related virus, could cause this neuromyelopathy, which is frequent in several tropical areas. Subsequent reports confirmed these findings in patients from Colombia and Jamaica (Rodgers-Johnson et al., 1985) , Africa (Gessain et al., 1986) , the Seychelle Islands (Roman et al., 1987) and the United States . In Japan a similar 0000-9118 © 1990 SGM 
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A. Gessain and others clinical entity was described and named HTLV-Iassociated myelopathy (HAM) (Osame et al., 1986) .
Although some HTLV-I-Iike retrovirus strains have been isolated from cultured peripheral blood mononuclear cells (PBMC) or CSF cells from patients with TSP (Jacobson et al., 1988; Gessain et al., 1989) or HAM (Hirose et al., 1986; Tsujimoto et aL, 1988) , complete characterization and comparisons with isolates of ATLL origin have yet to be achieved. Thus, to advance our understanding of the mechanism by which HTLN-I, or a closely related retroviral agent, induces neurological disorders it seems important to characterize a large number of new TSP-and HAM-derived strains from the diverse geographical areas of isolation.
In a recent report , we characterized three lymphoid cell lines and HTLV-I isolates from two TSP patients, natives of the French West Indies. Here we extend our study and establish six new virusproducing T cell lines with the same territorial origin. In addition, we examine three TSP lines obtained from patients from French Guyana and Central Africa. Our data examine the cell surface phenotype, the virus multiplication state and, more specifically, the characterization of the pattern of specific viral antigen expression. Moreover, we compare these data in virus producer ATLL-T cell lines generated from the French West Indian and African patients, and from prototype HTLV-I-infected cell lines.
Methods
Patients. Three groups of individuals were studied. The first group consisted of 10 patients (cases 1 to 10) diagnosed at Piti&Salp&ri6re Hospital (Paris, France) as suffering from TSP/HTLV-I on clinical and serological criteria, as previously described (Gessain et al., 1985; Vernant et al., 1987; Gout et al., 1989) . The second group was three patients (cases 11, 12 and 13) diagnosed as having acute ATLL on clinical, cytological and biological grounds and the third group included four other neurological patients, three with chronic paraplegia (cases 14, 15 and 16) and one with a pyramidal syndrome (case 17), all seronegative for HTLV-I. Blood peripheral lymphocytes from three healthy HTLV-I-seronegative men and one sample of cord blood cells from an HTLV-I-seronegative child were added as negative controls. The clinical and serological features of the patients studied are summarized in Table 1 .
Cell cultures. Blood was collected by venipuncture. PBMC were separated on a Ficoll gradient (Lymphoprep, Nyegaard) and cultivated at a density of 106 cells/ml in medium consisting of RPMI 1640 with 1 mM-HEPES (Flow Laboratories) supplemented with 20% heatinactivated foetal calf serum (Boehringer), 10% recombinant interleukin-2 (rIL2) (Boehringer) and antibiotics. The PBMC were initially stimulated with 1:400 phytohaemagglutinin (PHA) (Difco) for 3 days. Half of the medium was changed twice a week. From six of the 10 TSP patients CSF was obtained by lumbar puncture and cells were cocultivated (1 : 100) with cord blood mononuclear cells from a healthy HTLV-I-seronegative child of the opposite sex. Similar cocultures (1 : 1) were made with two other PBMC samples from TSP patients. PBMC ]" TSP/HTLV-I, tropical spastic paraparesis with serological evidence of HTLV-I infection; ATLL, adult T cell leukaemia/lymphoma.
:~ ND, Not done.
from patients l, 2, 3, 4, 6, 8, 10 and 11 were cultured for a second time, about 6 months (range 3 to 12 months) later. In total 33 samples were cultured under the conditions described above.
Immunofluorescence. Cell cultures were evaluated for expression of HTLV-I antigens by indirect immunofluorescence (IF) after acetone fixation . We used as specific reagents polyclonal anti-HTLV-I-positive sera and CSF from TSP patients, sera from ATLL patients and murine HTLV-I monoclonal anti-pl9 and p24 antibodies (DuPont). Negative controls were sera from healthy donors and a murine monoclonal rotavirus antibody (Roseto et al., 1983) . All sera were used at a dilution of 1:50. Fluorescein isothiocyanateconjugated goat anti-human or anti-mouse immunoglobulins (Institut Pasteur, Paris, France) were used as second antibodies.
Reverse transcriptase. Viral multiplication was estimated by measuring the particle-ass0ciated reverse transcriptase activity in culture supernatant fluids. The enzyme activity was determined as described by Poiesz et al. (1980) in the presence of Mg z÷.
Electron microscopy. Pelleted cells were fixed in 1% glutaraldehyde and dehydrated in serial baths of acetone before embedding in resin (LX112 Ladd). Sections were mounted on Formvar-carbon 150-mesh copper grids, stained with uranyl acetate and lead citrate and observed in a Philips EM301 electron microscope at a high accelerating voltage (60 kV).
Western blotting. For the Western blots approximately 1 x 10 v cells were solubilized at 4 °C in lysis buffer (0-1 M-Tris HC1 pH 7.4, 0.5~ sodium deoxycholate, 0.5 ~ Triton X-100, 0.05 % SDS) and electrophoresed using 5 to 15% SDS-polyacrylamide gels, according to Laemmli (1970) . Proteins were then electrophoretically transferred to 0.22 ~tm nitrocellulose membranes (Sartorius) as described by Towbin et al. (1979) . The blots were reacted with a 1 : 300 dilution of TSP patient sera for
HTL V-I T cell lines derived from TSP 3 3 5
2 h at 37 °C. After washing the blots were incubated with anti-human IgG (Fc-specific) conjugated to peroxidase (Sigma). Binding of antibodies was detected by staining with 4-chloro-l-naphthol (Sigma) in PBS with 0.05% HzO 2.
Surface phenotype characterization. The surface phenotype of the cultured cells was determined by standard indirect IF and cytofluorographic analysis (Chen et al., 1986 ) (model; Epic profile; Coulter) using a panel of monoclonal antibodies that recognize T-associated or Trestricted antigens (anti-CD2, -CD3, -CD4, -CD7 and -CD8) and Brestricted antigens (anti-CD19 and -CD20). Other monocional antibodies were also used: CD25, anti-MHC class II DR, CD33, CD41 and WT31, an antibody interacting with a monomorphic determinant present on CD3-Ti ~ and fl cells.
Results

Establishment of cell lines
During the initial days of culture, cells from patients and controls proliferated rapidly after PHA stimulation. An arrest in the growth curve was then observed for 2 to 4 weeks. At this time, cell proliferation again became evident in TSP-and ATLL-derived cultures (except in cases 5, 7 and 13), with the appearance of some cell clusters. As seen in Table 2 , 15 different long-term cell lines (after more than 4 months of growth; mean of 11 months) were established; these were 13 lines from PBMC alone, one (BAR/CSF) from CSF cells cocultivated with PBMC of an HTLV-I-seronegative adult, and one (BAR/C/TSP) from PBMC cocultivated with cord blood mononuclear cells. Chromosomal and HLA analyses (data not shown) revealed that the BAR/CSF cell line originated from the cells of the seronegative donor and that BAR/C/TSP came from the TSP patient. The 15 cell lines mostly grew as single cell suspensions, with a high percentage of anisocytosis, some cell aggregates and multinucleated giant cells. In the case of the remaining two TSP patients (cases 5 and 7), the four other neurological disease patients without detectable HTLV-I antibodies and the four healthy controls cells grew very slowly and finally died after several weeks. In the case of patient 13, a woman from the ivory Coast suffering from ATLL, cells died rapidly, probably because of a concomitant infection by human herpesvirus type 6 (Baurmann et al., 1988) .
All the cell lines remained dependent on exogenous rIL2, at 5 to 10% for optimal growth.
Cell surface phenotype
Most of the cell lines exhibited a pattern characteristic of CD 4+ activated T cells, with expression of CD2, CD3 and CD4 associated with a strong density of CD25 (TAC) and DR molecules. Furthermore the Ti ~/~ heterodimer was found to be expressed at a low density in the majority of the cells. CD7 was expressed in all the cells lines, but at a low density.
In five TSP cases, expression of CD8 was also detected in a significant number of cells (Table 3) . To assess the stability of antigen expression, the immunological phenotypes of most of the cell lines were analysed after different periods of culture (from 3 to 12 months). No significant modification was observed, even in the LER/B/TSP cell line, which shows a dual and stable expression of CD4 and CD8 activated T cells.
The B lymphocyte-associated antigens, CD19 and CD20, and the CD41 antigen were never detected at a significant level. CD33 antigen, usually expressed on myeloid cells, monocytes and macrophages, was expressed at a significant level in nine cases (from 10 to 67%), but at a low density.
Electron microscopy and virus production
Samples from the 12 TSP and the three ATLL lines were studied at regular intervals by electron microscopy. Cultures had a heterogeneous appearance with a mixture of small and large cells. However, the number of small cells that showed a typical lymphoid morphology, decreased with time and the large cells became predominant (Fig. 1 ). They were 10 to 16 ~tm in diameter and possessed convoluted nuclei containing coarse heterochromatin, generally in a thin perinuclear border and prominent nucleoli were common. It is noteworthy that in the ATLL cases the nuclei were sometimes less convoluted than the derived TSP cell lines. The cytoplasm contained numerous mitochondria, scarce and flattened rough endoplasmic reticulum, some lysosomes and fat or empty vesicles. Numerous microfilaments formed an irregular network in the cytoplasm as bundles lengthening within the frequent cytoplasmic projections, especially in the largest cells. Particular morphological features were noticed in some cases: nuclear blebs, complex nuclear bodies, bundles of perinuclear filaments, tubuloreticular structures within the endoplasmic reticulum and dense granules of 200 to 300 nm diameter. In two cases, after more than 6 months in culture, we observed the presence of giant multinucleated cells of up to 40 ~tm in diameter.
Virus particles were observed in the 15 cell lines. They appeared between 2 to 6 weeks after the beginning of the culture and, in all cases, after the onset of detectable positive immunofluorescence. The correlation between these two events was remarkable.
The viral particles were similar to those described in the HTLV-I carrier lines HUT-102 (Poiesz et al., 1980) or MT2 . The virions were extracellular, intermingled with vesiculomembranous debris. In long-term cultures they formed clusters close to the cell protein antibody (expressed in percentage of positive cells). 1" EM, electron microscopy: +, rare presence of HTLV-I particles; + +, frequent presence of HTLV-I particles; + + +, presence of numerous HTLV-I particles with 'budding'.
:~ ND, Not done. Table 3 . antibody  TSP  TSP  TSP  CSF  TSP  TSP  TSP  TSP  TSP  ATLL  ATLL  ATLL   CD2  99  94  98  94  92  96  92  98  99  98  99  99  CD3  99  84  99  97  78  86  50  92  94  88  92  98  CD4  99  95  99  82  45  79  21  97  83  97  93  95  CD7  40  87  44  90  91  38  22  90  87  86  96  48  CD8  4  10  3  22  33  20  52  2  30  7  15  9  CD19  4  10  1  4  6  4  5  2  4  5  5  3  CD20  3  13  2  4  5  3  3  2  6  4  3  2  CD25  97  77  91  75  46  70  81  87  83  71  93  90  CD33  15  54  23  10  13  16  7  66  67  8  6  24  CD41  4  9  16  3  4  2  3  2  6  NOt  3  5  DR  95  73  64  68  60  82  86  68  85  79  88  77  WT3I  91  73  97  91  56  35  17  82  73  58  80  94  MSIgG*  6  11  2  3  5  2  5  2  6  7  7  4 * Control antibody. "~ ND, Not done surface (Fig. 2a) , surrounding the very large cells (Fig. 1) . The virions had variable diameters ranging from 90 to 180nm (Fig. 2b) . Their nucleoids (50 to 100nm diameter) had a loosely arrayed aspect, sometimes had a polygonal profile and were surrounded by a round or slightly irregular outer envelope lacking spikes. Immature particles with an electron-lucent central nucleoid were occasionally seen. Budding forms with a crescentshaped nucleoid protruding under the plasma membrane (Fig. 2c) were rare, but after 6 months in culture they were more frequent in three cell lines, with several budding particles on single cell sections.
Phenotypic characterization of established T cell lines
Monoclonal COR/A/ COR/B/ BAR/C/ BAR/ SEP/A/ SOR/A/ LER/B/ BOU/A/ KOP/A/ GEN/A/ GEN/B/ BAT/A/
Low and variable levels of reverse transcriptase activity were detected in supernatant fluids of TSP-or ATLL-derived cell lines, but only after 4 to 5 months of culture, when at least 50 ~ of the cells exhibited HTLV-I antigens.
Indirect immunofluorescence
Viral antigen expression was never detected in fresh, uncultured PBMC. After short-term culture (7 to 15 days) viral antigens were detected in a low percentage of cells (1 to 7~) in all TSP cases (except patient 7) using either an anti-HTLV-I polyclonal serum from TSP, or a monoclonal HTLV-I p19 antibody ( Table 2 ). The percentage of fluorescent cells increased slowly until day 60, when expression was greatly increased in all cell lines, with the exception of cells from patient 2 (cocultures).
After several months, all of the established cell lines had 30 to 80~ IF-positive cells. However, it is interesting to point out that for each cell line the percentage of positive stained cells was always significantly higher when polyclonal rather than p19 monoclonal antibodies were employed. The p19 fluorescein-labelled area was located mainly in the periphery of the cells as small spots on the cell surface. All TSP long-term cell lines were also positive with HTLV-I p24 monoclonal antibody, but the intensity of staining was lower and more diffuse than with p19 antibody.
Concerning ATLL cell lines, antigen expression appeared earlier and the percentage of positive cells, after only a few days of culture, was higher than in TSP lines. The pattern of fluorescence staining using either polyclonal or monoclonal antibodies was similar to that found in TSP cell lines.
HTLV-I-specific polypeptides analysed by Western blotting
Eight TSP, two ATLL cell lines and infected and uninfected control cells were studied by Western blotting, using TSP patient sera (Fig. 3) . In all TSP and ATLL cell lines, bands corresponding to p53, p24 and p 19 viral core polypeptides were generally observed. The p15 structural protein was detected only in one TSP cell line (COR/A/TSP). The positive TSP sera also detected env-gene coded proteins and a 46K polypeptide was usually present, although weakly visible. A signal at about 62K was easily detectable in all TSP, but not in ATLL lines. In HUT-102 and MT2 cells, p57 and p56 polypeptides were observed, respectively. MT2 cells also contained the p68 molecule described by Takeuchi et al. (1985) . Moreover, two polypeptides of 40K and 36K were observed in nearly all cell lines. Additional 26K to 30K polypeptides were expressed with some variability in several cell lines (Table 4) .
Similar results were obtained with ATLL patient sera (data not shown), but the degree of sensitivity in detection of viral polypeptides was greatly reduced when ATLL sera were used. This fact could be related to the lower titres of HTLV-I-specific antibodies in ATLL compared to TSP.
Discussion
We established 12 T cell lines from eight patients with TSP. Nine of them were derived from natives of the French West Indies, two from French Guyana and one from a case from Central Africa. Concomitantly we obtained three lines from ATLL patients, two from a French West Indies patient and one from an African (Ivory Coast) patient. The KOP/A/TSP HTLV-I-producing T cell line is, as far as we know, the first viral isolate from an African patient with TSP, and the BAT/A/ATLL is one of the rare African ATLL isolates (Hahn et al., 1984; Baurmann et al., 1988) .
Regardless of their pathological and geographical origin the surface markers of the majority of established cells were those of mature, activated T cells (CD4 +, TAC + and DR+), comparable to the results reported by others in ATLL-derived lines (Hoshino et al., 1983; Markham et al., 1983; Del Mistro et al., 1986) . However, it is necessary to point out that in five TSP cases longterm T cell cultures from five patients also expressed CD8 at a significant level.
It is generally accepted, even if several exceptions have been reported, that T cell lines generated from ATLL PBMC become independent of exogenous IL2 after several months of culture (Markham et al., 1983) . Jacobson et al. (1988) suggested that IL2 dependence could be a phenotypic feature of TSP lines, but in our hands neither TSP lines nor ATLL, to date, became independent of this cellular growth factor.
Electron microscopy allowed us to detect numerous retroviral particles showing a morphology similar to that described for HTLV-I/ATLL prototype strains (Poiesz et al., 1980; Miyoshi et al., 1981) in all the TSP-and ATLLderived cell lines. Despite th e high number of type C particles observed in each case t h e accompanying reverse transcriptase activity in supernatant fluids was, without exception, absent or very low. This discrepancy may be related to the presence of the immature virions, or to mature but reverse transcriptase-defective virions. Alternatively, it might depend on the presence in the supernatants of some reverse transcriptase inhibitory factor(s) secreted by virus-infected cells. In any case, the low enzyme activity in virions could be the cause, or one of the causes, of the low efficiency of in vitro infection under acute conditions, peculiar to HTLV-I and, more particularly, to the isolates we describe.
Qualitative and/or quantitative differences in HTLV-I-specific antigenic expression could play a pathological role in TSP, as has been described for other virusinduced neurological disorders (ter Meulen et al., 1983) . Our examination by IF of virus antigen expression in TSP-T cell lines did not reveal any significant difference relative to the expression observed in ATLL-derived lines. We confirmed that no viral antigen was detectable by IF in freshly isolated TSP lymphocytes (Dalgleish et al., 1988; Gessain et al., 1989) and that IF becomes progressively positive during the evolution of the cultures. 
Protein patterns in the Western blots showed some degree of variability for a given cell line, probably depending on the number of passages. This makes it necessary to exercise great caution in interpreting isolated experiments. Nonetheless, there was a selective and consistent presence of p61-62 in all TSP-derived cell lines and an absence in ATLL-derived ones. This could suggest an immunopathogenic immune response in TSP patients, as compared to those suffering from T cell malignancy, with p61-62 playing a determinant role as an antigenic stimulus in TSP.
It remains to be explained why the great majority of the HTLV-I-infected subjects remain healthy carriers throughout their life, whereas others develop aggressive lymphoproliferation (ATLL) or a chronic disabling neurological disease (TSP/HAM). Several hypotheses have been proposed to explain these alternatives. On the one hand, different virus variants could be implicated in each of the pathological events; those determining ATLL would be preferentially lymphotropic, whereas those giving rise to chronic myelopathies would be neurotropic. However, comparative sequence analysis of virus strains isolated from ATLL and TSP/HAM have never shown any striking difference Reddy et al., 1988; Sarin et al., 1989) , although it is important to point out that only one TSP/HAM isolate has been sequenced (Tsujimoto et al., 1988) . In the murine paralytic diseases associated with retrovirus infection, very slight differences in the virus env gene have been shown to be related to fundamental changes in immunogenic and pathological properties (Rassart et al., 1986) . This could also prove to be the case with A. Gessain and others TSP/HAM retrovirus isolates. The HLA-related immune responsiveness of the host might also be an important factor in determining a particular pathology. A peculiar immunogenetic background in Japanese HAM patients has been found by Usuku et al. (1988) i who described a HAM-associated haplotype exhibiting a higher positive immune response to HTLV-! antigens than to ATLL-associated haplotypes. These data have yet to be confirmed in other areas in which TSP/HAM is endemic (Chavance et al., 1989) . Lastly, the source of infection, the viral load and other environmental cofactors could also be involved in the TSP/HAM pathogenesis.
The cell lines described in this article constitute convenient experimental substrates for further comparative studies on TSP and ATLL isolates. Molecular cloning of the virus in TSP cells is now in progress, as well as research into the proviral DNA status in vitro and in vivo and the regulation of viral protein expression.
